Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate

[1] Zhang X(2016)Drug delivery system targeting advanced hepatocellular carcinoma: Current and future Nanomedicine 12 853-69

[2] Ng HL(2015)Biodegradable particulate carrier formulation and tuning for targeted drug delivery J Biomed Nanotechnol 11 555-577

[3] Lu A(2011)RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells Adv Mater 23 H84-89

[4] Lin C(2015)Dual-Ligand modified polymer-lipid hybrid nanoparticles for docetaxel targeting delivery to Her2/neu overexpressed human breast cancer cells J Biomed Nanotechnol 11 1401-1417

[5] Zhou L(2014)Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo Pharm Res 31 3289-3303

[6] Lin G(2010)Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes Mol Pharm 7 1816-1826

[7] Tammam SN(2012)Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J Control Release: Off J Control Release Soc 160 264-273

[8] Azzazy HME(2010)Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int J Pharm 396 143-148

[9] Lamprecht A(2015)Functionalized nanocarriers for enhanced bioactive delivery to squamous cell carcinomas_ targeting approaches and related biopharmaceutical aspects Curr Pharm Des 2015 3167-3180

[10] Zhu S(2003)Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res 31 2717-2724

[1] Zhang X(2016)Drug delivery system targeting advanced hepatocellular carcinoma: Current and future Nanomedicine 12 853-69

[2] Ng HL(2015)Biodegradable particulate carrier formulation and tuning for targeted drug delivery J Biomed Nanotechnol 11 555-577

[3] Lu A(2011)RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells Adv Mater 23 H84-89

[4] Lin C(2015)Dual-Ligand modified polymer-lipid hybrid nanoparticles for docetaxel targeting delivery to Her2/neu overexpressed human breast cancer cells J Biomed Nanotechnol 11 1401-1417

[5] Zhou L(2014)Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo Pharm Res 31 3289-3303

[6] Lin G(2010)Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes Mol Pharm 7 1816-1826

[7] Tammam SN(2012)Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J Control Release: Off J Control Release Soc 160 264-273

[8] Azzazy HME(2010)Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int J Pharm 396 143-148

[9] Lamprecht A(2015)Functionalized nanocarriers for enhanced bioactive delivery to squamous cell carcinomas_ targeting approaches and related biopharmaceutical aspects Curr Pharm Des 2015 3167-3180

[10] Zhu S(2003)Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res 31 2717-2724